About MEAJO | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions to authors | Online submission | Subscribe | Advertise | Contact | Login 
Middle East African Journal of Ophthalmology Middle East African Journal of Ophthalmology
Users Online: 1525   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
This article has been cited by
1Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity
Sengul Ozdek,Metin Unlu,Gokhan Gurelik,Berati Hasanreisoglu
Journal of Optometry.2013;6(1)51
[DOI]
2Intravitreal Bevacizumab in Retinopathy of Prematurity
Dini Hapsari,Rita S. Sitorus
Asia-Pacific Journal of Ophthalmology.2014;3(6)368
[DOI]
3Intravitreal Bevacizumab for Retinopathy of Prematurity
Björn C. Harder,Stefan von Baltz,Jost B. Jonas,Frank C. Schlichtenbrede
Journal of Ocular Pharmacology and Therapeutics.2011;27(6)623
[DOI]
4Intravitreal Anti-VEGF Therapy as a Treatment for Retinopathy of Prematurity: What We Know After 7 Years
Michael A. Klufas,R. V. Paul Chan
Journal of Pediatric Ophthalmology & Strabismus.2015;52(2)77
[DOI]
5Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Hyun Goo Kang,Tae Young Kim,Jinu Han,Sueng-Han Han
Korean Journal of Ophthalmology.2019;33(3)272
[DOI]
6Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9
Venkateshnaidu Laveti,Divya Balakrishnan,Padmaja Kumari Rani,Ashik Mohamed,Subhadra Jalali
International Ophthalmology.2020;40(12)3539
[DOI]
7A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
Laura Pertl,Gernot Steinwender,Christoph Mayer,Silke Hausberger,Eva-Maria Pöschl,Werner Wackernagel,Andreas Wedrich,Yosuf El-Shabrawi,Anton Haas,Mary Elizabeth Hartnett
PLOS ONE.2015;10(6)e0129383
[DOI]
8Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Helen A. Mintz-Hittner,Kathleen A. Kennedy,Alice Z. Chuang
New England Journal of Medicine.2011;364(7)603
[DOI]
9Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
Lisa J. Faia,Michael T. Trese
New England Journal of Medicine.2013;364(7)1920
[DOI]
10Retinopathy of prematurity: recent developments in diagnosis and treatment
Birgit Lorenz,Knut Stieger
Expert Review of Ophthalmology.2015;10(2)167
[DOI]
11Retinopathy of prematurity treatment: Asian perspectives
Parveen Sen,Wei-Chi Wu,Parijat Chandra,Anand Vinekar,Pradeep T. Manchegowda,Pramod Bhende
Eye.2020;34(4)632
[DOI]
  Feedback 
  Subscribe 

Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal